BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30103944)

  • 1. c-Myc-driven glycolysis via TXNIP suppression is dependent on glutaminase-MondoA axis in prostate cancer.
    Qu X; Sun J; Zhang Y; Li J; Hu J; Li K; Gao L; Shen L
    Biochem Biophys Res Commun; 2018 Oct; 504(2):415-421. PubMed ID: 30103944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP.
    Shen L; O'Shea JM; Kaadige MR; Cunha S; Wilde BR; Cohen AL; Welm AL; Ayer DE
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5425-30. PubMed ID: 25870263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between Myc and MondoA transcription factors in metabolism and tumourigenesis.
    Wilde BR; Ayer DE
    Br J Cancer; 2015 Dec; 113(11):1529-33. PubMed ID: 26469830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer.
    Pan T; Gao L; Wu G; Shen G; Xie S; Wen H; Yang J; Zhou Y; Tu Z; Qian W
    Biochem Biophys Res Commun; 2015 Jan; 456(1):452-8. PubMed ID: 25482439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity.
    Kaadige MR; Looper RE; Kamalanaadhan S; Ayer DE
    Proc Natl Acad Sci U S A; 2009 Sep; 106(35):14878-83. PubMed ID: 19706488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MondoA-Mlx transcriptional activity is limited by mTOR-MondoA interaction.
    Kaadige MR; Yang J; Wilde BR; Ayer DE
    Mol Cell Biol; 2015 Jan; 35(1):101-10. PubMed ID: 25332233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MondoA-Thioredoxin-Interacting Protein Axis Maintains Regulatory T-Cell Identity and Function in Colorectal Cancer Microenvironment.
    Lu Y; Li Y; Liu Q; Tian N; Du P; Zhu F; Han Y; Liu X; Liu X; Peng X; Wang X; Wu Y; Tong L; Li Y; Zhu Y; Wu L; Zhang P; Xu Y; Chen H; Li B; Tong X
    Gastroenterology; 2021 Aug; 161(2):575-591.e16. PubMed ID: 33901495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2.
    Xiao D; Ren P; Su H; Yue M; Xiu R; Hu Y; Liu H; Qing G
    Oncotarget; 2015 Dec; 6(38):40655-66. PubMed ID: 26528759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MondoA senses adenine nucleotides: transcriptional induction of thioredoxin-interacting protein.
    Han KS; Ayer DE
    Biochem J; 2013 Jul; 453(2):209-18. PubMed ID: 23631812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose sensing by MondoA:Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression.
    Stoltzman CA; Peterson CW; Breen KT; Muoio DM; Billin AN; Ayer DE
    Proc Natl Acad Sci U S A; 2008 May; 105(19):6912-7. PubMed ID: 18458340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
    Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
    Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications.
    Iqbal MA; Chattopadhyay S; Siddiqui FA; Ur Rehman A; Siddiqui S; Prakasam G; Khan A; Sultana S; Bamezai RN
    FEBS J; 2021 Jan; 288(2):471-485. PubMed ID: 32356386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TXNIP induced by MondoA, rather than ChREBP, suppresses cervical cancer cell proliferation, migration and invasion.
    Zhang J; Tian X; Yin H; Xiao S; Yi S; Zhang Y; Zeng F
    J Biochem; 2020 Apr; 167(4):371-377. PubMed ID: 31782782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MondoA senses non-glucose sugars: regulation of thioredoxin-interacting protein (TXNIP) and the hexose transport curb.
    Stoltzman CA; Kaadige MR; Peterson CW; Ayer DE
    J Biol Chem; 2011 Nov; 286(44):38027-38034. PubMed ID: 21908621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioredoxin-interacting protein (Txnip) gene expression: sensing oxidative phosphorylation status and glycolytic rate.
    Yu FX; Chai TF; He H; Hagen T; Luo Y
    J Biol Chem; 2010 Aug; 285(33):25822-30. PubMed ID: 20558747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An extended Myc network contributes to glucose homeostasis in cancer and diabetes.
    Peterson CW; Ayer DE
    Front Biosci (Landmark Ed); 2011 Jun; 16(6):2206-23. PubMed ID: 21622171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional and Translational Downregulation of Thioredoxin Interacting Protein Is Required for Metabolic Reprogramming during G(1).
    Elgort MG; O'Shea JM; Jiang Y; Ayer DE
    Genes Cancer; 2010 Sep; 1(9):893-907. PubMed ID: 21779470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor independent down-regulation of thioredoxin-interacting protein in hypoxia.
    Chai TF; Leck YC; He H; Yu FX; Luo Y; Hagen T
    FEBS Lett; 2011 Feb; 585(3):492-8. PubMed ID: 21192937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of pyruvate kinase (PK) activity causes glycolytic intermediate imbalances and reveals a PK-TXNIP regulatory axis.
    Nieborak A; Lukauskas S; Capellades J; Heyn P; Santos GS; Motzler K; Zeigerer A; Bester R; Protzer U; Schelter F; Wagner M; Carell T; Hruscha A; Schmid B; Yanes O; Schneider R
    Mol Metab; 2023 Aug; 74():101748. PubMed ID: 37290673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.